Prostate cancer diagnoses have reached a record high after campaigns urging men to come forward for checks. Official data ...

Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023, according to NHS data. It’s also the second-deadliest form of the ...

A sustained reduction in deaths from prostate cancer was observed with prostate-specific antigen (PSA) testing in long-term ...

After 23 years of follow-up, the European Randomized Study of Screening for Prostate Cancer (ERSPC) confirmed a 13% lower ...

This is an opinion column. Sometimes I get mixed up. That’s not unusual. Not at this age. You’d think, though, that I’d be crystal clear about my prostate cancer treatment. About the active ...

Editor's note: Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and an assistant professor at the University of Central Florida’s College of Medicine.When I learned that ...

MEN with suspected prostate cancer will be able to get a diagnosis on the NHS within a day, under “game-changing” new trials.

We demonstrate that patients with luminal B tumors derive clinically meaningful benefits … from the addition of apalutamide to secondary radiotherapy,” Dr Daniel Spratt said, adding that these ...

A new drug combination to treat advanced recurring prostate cancer has shown remarkable results in a long-term trial, ...

“This study adjusted for testosterone levels, which can influence PSA and outcomes, and still found a significant association. This strengthens the argument that PSA response to neoadjuvant therapy is ...